Impilo

Company

Last mentioned: Feb 26, 2026

Stories mentioning Impilo 2

acquisition Neutral

Scantox Bolsters Genetic Toxicology Portfolio with TwinStrand Acquisition

Scantox has acquired the DuplexSeq™ nonclinical genomics safety business from TwinStrand Biosciences, integrating ultra-sensitive DNA sequencing technology into its preclinical CRO services. The move positions Scantox as a leader in high-precision genetic toxicology, offering pharmaceutical clients 10,000x greater sensitivity in identifying mutagenic risks.

2 sources
acquisition Neutral

Scantox Bolsters Genetic Toxicology via TwinStrand DuplexSeq Acquisition

Scantox has acquired the DuplexSeq™ nonclinical genomics safety business from TwinStrand Biosciences, integrating ultra-sensitive DNA sequencing into its pre-clinical service portfolio. The move positions Scantox as a leader in next-generation genetic toxicology, offering 10,000x higher sensitivity than standard sequencing methods.

2 sources